Preoperative MELD Score Predicts Mortality and Adverse Outcomes Following Radical Cystectomy: Analysis of American College of Surgeons National Surgical Quality Improvement Program

Overview

Journal Ther Adv Urol

Publisher Sage Publications

Date 2022 Nov 21

PMID 36407007

Authors

Christian Habib Ayoub

Ali Dakroub

Jose M El-Asmar

Adel Hajj Ali

Hadi Beaini

Suhaib Abdulfattah

Albert El Hajj

Affiliations

Soon will be listed here.

Abstract

Background: The model for end-stage liver disease (MELD) has been widely used to predict the mortality and morbidity of various surgical procedures.

Objectives: We aimed to correlate a high preoperative MELD score with adverse 30-day postoperative complications following radical cystectomy.

Design And Methods: Patients who underwent elective, non-emergency radical cystectomy were identified from the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2017. Patients were categorized according to a calculated MELD score. The primary outcomes of this study were 30-day postoperative mortality, morbidity, and length of hospital stay following radical cystectomy. For further sensitivity analysis, propensity score matching was used to yield a total of 1387 matched pairs and primary outcomes were also assessed in the matched cohort.

Results: Compared with patients with a MELD < 10, those with MELD ⩾ 10 had significantly higher rates of mortality [odds ratio (OR) = 1.71, 0.004], major complications (OR = 1.42, 0.001), and prolonged hospital stay (OR = 1.29, 0.001) on multivariate analysis. Following risk-adjustment for race, propensity-matched groups revealed that patients with MELD score ⩾ 10 were significantly associated with higher mortality (OR = 1.85, 0.008), major complications (OR = 1.34, 0.001), yet similar length of hospital stay (OR = 1.17, 0.072).

Conclusion: MELD score ⩾ 10 is associated with higher mortality and morbidity in patients undergoing radical cystectomy compared with lower MELD scores. Risk-stratification using MELD score may assist clinicians in identifying high-risk patients to provide adequate preoperative counseling, optimize perioperative conditions, and even consider nonsurgical alternatives.

Citing Articles

Preoperative predictors of prolonged length of stay in radical cystectomy: a retrospective study using the American College of Surgeons-National Surgical Quality Improvement Program Dataset.

Abou Chawareb E, Ayoub C, Najdi J, Ghoubaira J, El-Hajj A Ther Adv Urol. 2023; 15:17562872231191654.

PMID: 37577029 PMC: 10413889. DOI: 10.1177/17562872231191654.

References

Hautmann R, de Petriconi R, Volkmer B . Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010; 184(3):990-4. DOI: 10.1016/j.juro.2010.05.037. View

Minhem M, Sarkis S, Safadi B, Fares S, Alami R . Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program. Obes Surg. 2018; 28(9):2844-2851. DOI: 10.1007/s11695-018-3259-z. View

Elting L, Pettaway C, Bekele B, Grossman H, Cooksley C, Avritscher E . Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer. 2005; 104(5):975-84. DOI: 10.1002/cncr.21273. View

Mastroianni R, Ferriero M, Tuderti G, Anceschi U, Bove A, Brassetti A . Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial. J Urol. 2022; 207(5):982-992. DOI: 10.1097/JU.0000000000002422. View

Witjes J, Bruins H, Cathomas R, Comperat E, Cowan N, Gakis G . European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2020; 79(1):82-104. DOI: 10.1016/j.eururo.2020.03.055. View

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P . Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124(1):91-6. DOI: 10.1053/gast.2003.50016. View

Causey M, Nelson D, Johnson E, Maykel J, Davis B, Rivadeneira D . The impact of Model for End-Stage Liver Disease-Na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease. Am J Surg. 2013; 207(4):520-6. DOI: 10.1016/j.amjsurg.2013.06.008. View

Mansour A, Watson W, Shayani V, Pickleman J . Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997; 122(4):730-5; discussion 735-6. DOI: 10.1016/s0039-6060(97)90080-5. View

Jacob M, Copley L, Lewsey J, Gimson A, Toogood G, Rela M . Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl. 2004; 10(7):903-7. DOI: 10.1002/lt.20169. View

10.

Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C . A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-70. DOI: 10.1053/jhep.2001.22172. View

11.

Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C . Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol. 2013; 37(3):219-25. DOI: 10.1016/j.canep.2013.02.002. View

12.

Al Abbas A, Borrebach J, Bellon J, Zureikat A . Does Preoperative MELD Score Predict Adverse Outcomes Following Pancreatic Resection: an ACS NSQIP Analysis. J Gastrointest Surg. 2019; 24(10):2259-2268. DOI: 10.1007/s11605-019-04380-0. View

13.

Quek M, Stein J, Daneshmand S, Miranda G, Thangathurai D, Roffey P . A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006; 175(3 Pt 1):886-9. DOI: 10.1016/S0022-5347(05)00421-0. View

14.

Bochner B, Dalbagni G, Sjoberg D, Silberstein J, Paz G, Donat S . Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2014; 67(6):1042-1050. PMC: 4424172. DOI: 10.1016/j.eururo.2014.11.043. View

15.

Krafcik B, Farber A, Eslami M, Kalish J, Rybin D, Doros G . The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass. J Vasc Surg. 2016; 64(1):124-30. DOI: 10.1016/j.jvs.2016.01.033. View

16.

Monn M, Kaimakliotis H, Cary K, Pedrosa J, Flack C, Koch M . Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy. Urol Oncol. 2014; 32(8):1151-7. DOI: 10.1016/j.urolonc.2014.04.009. View

17.

Isbarn H, Jeldres C, Zini L, Perrotte P, Baillargeon-Gagne S, Capitanio U . A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol. 2009; 182(1):70-7. DOI: 10.1016/j.juro.2009.02.120. View

18.

Crozier J, Hennessey D, Sengupta S, Bolton D, Lawrentschuk N . A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer. Urology. 2016; 96:74-79. DOI: 10.1016/j.urology.2016.06.034. View

19.

Morimoto N, Okada K, Okita Y . The model for end-stage liver disease (MELD) predicts early and late outcomes of cardiovascular operations in patients with liver cirrhosis. Ann Thorac Surg. 2013; 96(5):1672-8. DOI: 10.1016/j.athoracsur.2013.06.007. View

20.

Saginala K, Barsouk A, Aluru J, Rawla P, Padala S, Barsouk A . Epidemiology of Bladder Cancer. Med Sci (Basel). 2020; 8(1). PMC: 7151633. DOI: 10.3390/medsci8010015. View